Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Metformin

  • Open Access
    Advantages and Disadvantages of Drug Combination Treatment: Riluzole, Metformin and Dexamethasone Effect on Glioblastoma Cell
    JONATHAN KEUL, SWETLANA SPERLING, VEIT ROHDE and MILENA NINKOVIC
    Anticancer Research May 2025, 45 (5) 1813-1823; DOI: https://doi.org/10.21873/anticanres.17561
  • You have access
    Design and Evaluation of a Humanized Anti-EGFR huscFv Antibody Fragment in Combination With Metformin in A549 Cells In Vitro
    JORGE SOLIS-ESTRADA, EDER ARREDONDO-ESPINOZA, ELIZETH PIOQUINTO-ÁVILA, ALDO O. GONZÁLEZ-CRUZ, XRISTO ZARATE and ISAÍAS BALDERAS-RENTERÍA
    Anticancer Research May 2024, 44 (5) 1955-1962; DOI: https://doi.org/10.21873/anticanres.16998
  • Open Access
    Metformin in Conjunction With Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer: Long-term Results of a Prospective Phase II Clinical Trial
    MOLLY K. TATE, MIKE HERNANDEZ, JOE Y. CHANG, STEVEN H. LIN, ZHONGXING LIAO, SUJA M. KOSHY, HEATH D. SKINNER and STEPHEN G. CHUN
    Anticancer Research January 2024, 44 (1) 133-137; DOI: https://doi.org/10.21873/anticanres.16795
  • Open Access
    Oxidative Stress-regulating Enzymes and Endometrial Cancer Survival in Relation to Metformin Intake in Diabetic Patients
    EWELINA KUUSINIEMI, PEETER KARIHTALA, ULLA PUISTOLA, ANNE AHTIKOSKI and ELINA URPILAINEN
    Anticancer Research December 2023, 43 (12) 5545-5554; DOI: https://doi.org/10.21873/anticanres.16756
  • You have access
    Knockdown of NUPR1 Enhances the Sensitivity of Non-small-cell Lung Cancer Cells to Metformin by AKT Inhibition
    YU JIN KIM, SUNG-EUN HONG, SE-KYEONG JANG, KI SOO PARK, CHUN-HO KIM, IN-CHUL PARK and HYEON-OK JIN
    Anticancer Research July 2022, 42 (7) 3475-3481; DOI: https://doi.org/10.21873/anticanres.15834
  • You have access
    Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?
    CHIARA CICCARESE, ROBERTO IACOVELLI, SEBASTIANO BUTI, FRANCESCA PRIMI, SERENA ASTORE, FRANCESCO MASSARI, MIRIAM GRAZIA FERRARA, GIUSEPPE PALERMO, NAZARIO FOSCHI, VALERIO IACOVELLI, ERNESTO ROSSI, GIOVANNI SCHINZARI, PIERLUIGI BOVE, PIERFRANCESCO BASSI, EMILIO BRIA and GIAMPAOLO TORTORA
    Anticancer Research March 2022, 42 (3) 1487-1493; DOI: https://doi.org/10.21873/anticanres.15620
  • You have access
    Enhancement of Radiation Response Associated With Metformin in Hepatocellular Carcinoma: Preclinical Animal and Clinical Cohort Study
    WON IL JANG, MI-SOOK KIM, JAE-HOON JEONG, WONWOO KIM and JAE SUNG KIM
    Anticancer Research February 2022, 42 (2) 867-876; DOI: https://doi.org/10.21873/anticanres.15544
  • You have access
    Repurposing Metformin for Cancer Treatment: A Great Challenge of a Promising Drug
    CHARUPONG SAENGBOONMEE, THANACHAI SANLUNG and SOPIT WONGKHAM
    Anticancer Research December 2021, 41 (12) 5913-5918; DOI: https://doi.org/10.21873/anticanres.15410
  • You have access
    Inhibition of AKT Enhances the Sensitivity of NSCLC Cells to Metformin
    SE-KYEONG JANG, SUNG-EUN HONG, DA-HEE LEE, JI YEA KIM, JI-YOUNG KIM, JUNGIL HONG, IN-CHUL PARK and HYEON-OK JIN
    Anticancer Research July 2021, 41 (7) 3481-3487; DOI: https://doi.org/10.21873/anticanres.15135
  • You have access
    Effect of Metformin in Combination With Trametinib and Paclitaxel on Cell Survival and Metastasis in Melanoma Cells
    YOUNGKI LEE and DEOKBAE PARK
    Anticancer Research March 2021, 41 (3) 1387-1399; DOI: https://doi.org/10.21873/anticanres.14896

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire